What is Ocular Therapeutix's cash ratio?

Ocular Therapeutix (OCUL) reported cash ratio of 14× in Q1 2026.

How has Ocular Therapeutix's cash ratio changed year-over-year?

Ocular Therapeutix's cash ratio increased by 51.6% year-over-year, from 9.2× to 14×.

What is the long-term trend for Ocular Therapeutix's cash ratio?

Over 5 years (2020 to 2025), Ocular Therapeutix's cash ratio has grown at a 11.1% compound annual growth rate (CAGR), from 8.6× to 14.5×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Ocular Therapeutix OCUL Cash ratio

Cash ratio at other companies

Regeneron PharmaceuticalsREGN

0.6×-0.3×

Bausch + LombBLCO

0.2×0.0×

Tarsus Pharmaceuticals, Inc.TARS

0.7×-1.3×

Kodiak Sciences IncKOD

3.4×-1.1×

Ultragenyx PharmaceuticalRARE

0.5×+0.1×

PBH

Prestige Consumer HealthcarePBH

0.5×-0.4×

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

cash and equivalents/total current liabilities=14×

Based on the most recent quarter.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's cash ratio?: Ocular Therapeutix (OCUL) reported cash ratio of 14× in Q1 2026.
How has Ocular Therapeutix's cash ratio changed year-over-year?: Ocular Therapeutix's cash ratio increased by 51.6% year-over-year, from 9.2× to 14×.
What is the long-term trend for Ocular Therapeutix's cash ratio?: Over 5 years (2020 to 2025), Ocular Therapeutix's cash ratio has grown at a 11.1% compound annual growth rate (CAGR), from 8.6× to 14.5×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.